In prostate cancer cells, Mdm2 competes with E3 ubiquitin ligase SCFSkp2 to bind to E2F1 and inhibits the ubiquitination of E2F1, thereby up-regulating the protein level of E2F1 [106]. Here, E2F1 is linked to prostate cancer.